Cassava Sciences
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell SAVA and other ETFs, options, and stocks.About SAVA
Cassava Sciences, Inc. engages in the development of novel drugs and diagnostics. It focuses on developing product candidates intended for the treatment of Alzheimer’s disease, including PTI-125 and PTI-125Dx.
CEORichard Jon Barry
CEORichard Jon Barry
Employees30
Employees30
HeadquartersAustin, Texas
HeadquartersAustin, Texas
Founded1998
Founded1998
Employees30
Employees30
SAVA Key Statistics
Market cap141.78M
Market cap141.78M
Price-Earnings ratio-1.33
Price-Earnings ratio-1.33
Dividend yield—
Dividend yield—
Average volume760.62K
Average volume760.62K
High today$2.94
High today$2.94
Low today$2.93
Low today$2.93
Open price$3.16
Open price$3.16
Volume7.40K
Volume7.40K
52 Week high$4.98
52 Week high$4.98
52 Week low$1.15
52 Week low$1.15
Stock Snapshot
As of today, Cassava Sciences(SAVA) shares are valued at $2.93. The company's market cap stands at 141.78M, with a P/E ratio of -1.33.
During the trading session on 2025-12-15, Cassava Sciences(SAVA) shares reached a daily high of $2.94 and a low of $2.93. At a current price of $2.93, the stock is 0.0% higher than the low and still -0.3% under the high.
Trading activity shows a volume of 7.4K, compared to an average daily volume of 760.62K.
Over the past 52 weeks, Cassava Sciences(SAVA) stock has traded between a high of $4.98 and a low of $1.15.
Over the past 52 weeks, Cassava Sciences(SAVA) stock has traded between a high of $4.98 and a low of $1.15.
People also own
Based on the portfolios of people who own SAVA. This list is generated using Robinhood data, and it’s not a recommendation.